相关实验视频

Updated: Jan 10, 2026

Murine Bilateral Renal Lymphadenectomy

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

在一个患有经常复发的,依赖于类固醇的脏病综合征的儿童中,贝利穆马布与mycophenolate mofetil结合使用

Yi Mao^1,2, Jia He¹, Weijie Kang¹

¹Department of Nephrology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, 1678 Dongfang Road, Pudong District, Shanghai, 200127, China.

Pediatric nephrology (Berlin, Germany)

|November 24, 2025

概括

贝利马布为儿童经常复发的类固醇依赖性性综合征 (FRNS/SDNS) 提供了潜在的新疗法. 这种B细胞激活因子 (BAFF) 抑制剂帮助一名患者在Rituximab不耐受后实现缓解.

科学领域:

儿科脏病学儿科脏病学
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

经常复发的类固醇依赖性性综合征 (FRNS/SDNS) 提出了重大治疗挑战.
利图西马布是一种常见的治疗方法,但存在严重副作用的风险.
贝利马布是一种针对BAFF的抗体,已被批准用于全身性红斑狼 (SLE) 和狼性炎 (LN).

研究的目的:

报告贝利马布在FRNS/SDNS的儿科患者的成功使用情况.
在Rituximab不耐受或禁忌的情况下,评估belimumab作为替代品.

主要方法:

治疗了一例FRNS/SDNS对标准治疗不耐药,对rituximab不耐受的儿科病例.
贝利马布被添加到现有的mycophenolate mofetil (MMF) 治疗中.
监测治疗结果,包括缓解状态和不良事件.

主要成果:

患者在戒除类固醇近一年的时间内实现并保持了完全缓解.
贝利穆马布耐受性良好,没有报告严重不良事件.
这种疗法在一个难以治疗的FRNS/SDNS病例中显示出有效性.

结论:

贝利马布与MMF结合可能是儿科FRNS/SDNS的有效治疗选择,特别是对rituximab不耐受的患者.
需要对更大的队列进行进一步的研究,以确认有效性和安全性.
这一案例凸显了贝利马布在治疗耐火性性综合征方面的潜力.

关键词:

B细胞激活因子激活因子贝利穆姆巴巴的情况案例报告案例报告脏病综合征 - 脏病综合征

更多相关视频

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

Nephrotic Syndrome II : Assessment and Medical Management

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Nephrotic Syndrome III : Nursing Management

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...